Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss

Despite the relevant research efforts, the causes of amyotrophic lateral sclerosis (ALS) are still unknown and no effective cure is available. Many authors suggest that ALS is a multi-system disease caused by a network failure instead of a cell-autonomous pathology restricted to motoneurons. Althoug...

Full description

Bibliographic Details
Main Authors: Rosario Gulino, Nunzio Vicario, Maria A.S. Giunta, Graziana Spoto, Giovanna Calabrese, Michele Vecchio, Massimo Gulisano, Giampiero Leanza, Rosalba Parenti
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/6/1500
id doaj-abc3defac24a4eb6967e030e5141ded0
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Rosario Gulino
Nunzio Vicario
Maria A.S. Giunta
Graziana Spoto
Giovanna Calabrese
Michele Vecchio
Massimo Gulisano
Giampiero Leanza
Rosalba Parenti
spellingShingle Rosario Gulino
Nunzio Vicario
Maria A.S. Giunta
Graziana Spoto
Giovanna Calabrese
Michele Vecchio
Massimo Gulisano
Giampiero Leanza
Rosalba Parenti
Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss
International Journal of Molecular Sciences
neurodegeneration
spinal cord
gastrocnemius muscle
CTB-Saporin
neuronal plasticity
AMPA receptor
motoneuron
astrocyte
author_facet Rosario Gulino
Nunzio Vicario
Maria A.S. Giunta
Graziana Spoto
Giovanna Calabrese
Michele Vecchio
Massimo Gulisano
Giampiero Leanza
Rosalba Parenti
author_sort Rosario Gulino
title Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss
title_short Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss
title_full Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss
title_fullStr Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss
title_full_unstemmed Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss
title_sort neuromuscular plasticity in a mouse neurotoxic model of spinal motoneuronal loss
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2019-03-01
description Despite the relevant research efforts, the causes of amyotrophic lateral sclerosis (ALS) are still unknown and no effective cure is available. Many authors suggest that ALS is a multi-system disease caused by a network failure instead of a cell-autonomous pathology restricted to motoneurons. Although motoneuronal loss is the critical hallmark of ALS given their specific vulnerability, other cell populations, including muscle and glial cells, are involved in disease onset and progression, but unraveling their specific role and crosstalk requires further investigation. In particular, little is known about the plastic changes of the degenerating motor system. These spontaneous compensatory processes are unable to halt the disease progression, but their elucidation and possible use as a therapeutic target represents an important aim of ALS research. Genetic animal models of disease represent useful tools to validate proven hypotheses or to test potential therapies, and the conception of novel hypotheses about ALS causes or the study of pathogenic mechanisms may be advantaged by the use of relatively simple <i>in vivo</i> models recapitulating specific aspects of the disease, thus avoiding the inclusion of too many confounding factors in an experimental setting. Here, we used a neurotoxic model of spinal motoneuron depletion induced by injection of cholera toxin-B saporin in the gastrocnemius muscle to investigate the possible occurrence of compensatory changes in both the muscle and spinal cord. The results showed that, following the lesion, the skeletal muscle became atrophic and displayed electromyographic activity similar to that observed in ALS patients. Moreover, the changes in muscle fiber morphology were different from that observed in ALS models, thus suggesting that some muscular effects of disease may be primary effects instead of being simply caused by denervation. Notably, we found plastic changes in the surviving motoneurons that can produce a functional restoration probably similar to the compensatory changes occurring in disease. These changes could be at least partially driven by glutamatergic signaling, and astrocytes contacting the surviving motoneurons may support this process.
topic neurodegeneration
spinal cord
gastrocnemius muscle
CTB-Saporin
neuronal plasticity
AMPA receptor
motoneuron
astrocyte
url https://www.mdpi.com/1422-0067/20/6/1500
work_keys_str_mv AT rosariogulino neuromuscularplasticityinamouseneurotoxicmodelofspinalmotoneuronalloss
AT nunziovicario neuromuscularplasticityinamouseneurotoxicmodelofspinalmotoneuronalloss
AT mariaasgiunta neuromuscularplasticityinamouseneurotoxicmodelofspinalmotoneuronalloss
AT grazianaspoto neuromuscularplasticityinamouseneurotoxicmodelofspinalmotoneuronalloss
AT giovannacalabrese neuromuscularplasticityinamouseneurotoxicmodelofspinalmotoneuronalloss
AT michelevecchio neuromuscularplasticityinamouseneurotoxicmodelofspinalmotoneuronalloss
AT massimogulisano neuromuscularplasticityinamouseneurotoxicmodelofspinalmotoneuronalloss
AT giampieroleanza neuromuscularplasticityinamouseneurotoxicmodelofspinalmotoneuronalloss
AT rosalbaparenti neuromuscularplasticityinamouseneurotoxicmodelofspinalmotoneuronalloss
_version_ 1716823810117730304
spelling doaj-abc3defac24a4eb6967e030e5141ded02020-11-24T20:41:56ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-03-01206150010.3390/ijms20061500ijms20061500Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal LossRosario Gulino0Nunzio Vicario1Maria A.S. Giunta2Graziana Spoto3Giovanna Calabrese4Michele Vecchio5Massimo Gulisano6Giampiero Leanza7Rosalba Parenti8Laboratory of Neurophysiology, Department of Biomedical and Biotechnological Science, Section of Physiology, University of Catania, Catania 95123, ItalyLaboratory of Cellular and Molecular Physiology, Department of Biomedical and Biotechnological Sciences, Section of Physiology, University of Catania, Catania 95123, ItalyLaboratory of Cellular and Molecular Physiology, Department of Biomedical and Biotechnological Sciences, Section of Physiology, University of Catania, Catania 95123, ItalyLaboratory of Cellular and Molecular Physiology, Department of Biomedical and Biotechnological Sciences, Section of Physiology, University of Catania, Catania 95123, ItalyLaboratory of Cellular and Molecular Physiology, Department of Biomedical and Biotechnological Sciences, Section of Physiology, University of Catania, Catania 95123, ItalyRehabilitation Unit, “AOU Policlinico Vittorio Emanuele” and Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania 95123, ItalyLaboratory of Synthetic and Systems Biology, Department of Drug Sciences, University of Catania, Catania 95125, ItalyLaboratory of Neurogenesis and Repair, Department of Drug Sciences, University of Catania, Catania 95125, ItalyLaboratory of Cellular and Molecular Physiology, Department of Biomedical and Biotechnological Sciences, Section of Physiology, University of Catania, Catania 95123, ItalyDespite the relevant research efforts, the causes of amyotrophic lateral sclerosis (ALS) are still unknown and no effective cure is available. Many authors suggest that ALS is a multi-system disease caused by a network failure instead of a cell-autonomous pathology restricted to motoneurons. Although motoneuronal loss is the critical hallmark of ALS given their specific vulnerability, other cell populations, including muscle and glial cells, are involved in disease onset and progression, but unraveling their specific role and crosstalk requires further investigation. In particular, little is known about the plastic changes of the degenerating motor system. These spontaneous compensatory processes are unable to halt the disease progression, but their elucidation and possible use as a therapeutic target represents an important aim of ALS research. Genetic animal models of disease represent useful tools to validate proven hypotheses or to test potential therapies, and the conception of novel hypotheses about ALS causes or the study of pathogenic mechanisms may be advantaged by the use of relatively simple <i>in vivo</i> models recapitulating specific aspects of the disease, thus avoiding the inclusion of too many confounding factors in an experimental setting. Here, we used a neurotoxic model of spinal motoneuron depletion induced by injection of cholera toxin-B saporin in the gastrocnemius muscle to investigate the possible occurrence of compensatory changes in both the muscle and spinal cord. The results showed that, following the lesion, the skeletal muscle became atrophic and displayed electromyographic activity similar to that observed in ALS patients. Moreover, the changes in muscle fiber morphology were different from that observed in ALS models, thus suggesting that some muscular effects of disease may be primary effects instead of being simply caused by denervation. Notably, we found plastic changes in the surviving motoneurons that can produce a functional restoration probably similar to the compensatory changes occurring in disease. These changes could be at least partially driven by glutamatergic signaling, and astrocytes contacting the surviving motoneurons may support this process.https://www.mdpi.com/1422-0067/20/6/1500neurodegenerationspinal cordgastrocnemius muscleCTB-Saporinneuronal plasticityAMPA receptormotoneuronastrocyte